Mitochondrial DNA mutations in Malaysian female breast cancer patients

Cancer development has been ascribed with diverse genetic variations which are identified in both mitochondrial and nuclear genomes. Mitochondrial DNA (mtDNA) alterations have been detected in several tumours which include lung, colorectal, renal, pancreatic and breast cancer. Several studies have e...

Full description

Bibliographic Details
Main Authors: Omasanggar, Raevathi, Yu, Choo Yee, Ang, Geik Yong, Emran, Nor Aina, Kitan, Normayah, Baghawi, Anita, Ahmad, Atiki Falparado, Abdullah, Maizaton Atmadini, Teh, Lay Kek, Maniam, Sandra
Format: Article
Language:English
Published: Public Library of Science 2020
Online Access:http://psasir.upm.edu.my/id/eprint/86771/1/Mitochondrial%20DNA%20mutations%20in%20Malaysian%20female%20breast%20cancer%20patients.pdf
_version_ 1825952260352376832
author Omasanggar, Raevathi
Yu, Choo Yee
Ang, Geik Yong
Emran, Nor Aina
Kitan, Normayah
Baghawi, Anita
Ahmad, Atiki Falparado
Abdullah, Maizaton Atmadini
Teh, Lay Kek
Maniam, Sandra
author_facet Omasanggar, Raevathi
Yu, Choo Yee
Ang, Geik Yong
Emran, Nor Aina
Kitan, Normayah
Baghawi, Anita
Ahmad, Atiki Falparado
Abdullah, Maizaton Atmadini
Teh, Lay Kek
Maniam, Sandra
author_sort Omasanggar, Raevathi
collection UPM
description Cancer development has been ascribed with diverse genetic variations which are identified in both mitochondrial and nuclear genomes. Mitochondrial DNA (mtDNA) alterations have been detected in several tumours which include lung, colorectal, renal, pancreatic and breast cancer. Several studies have explored the breast tumour-specific mtDNA alteration mainly in Western population. This study aims to identify mtDNA alterations of 20 breast cancer patients in Malaysia by next generation sequencing analysis. Twenty matched tumours with corresponding normal breast tissues were obtained from female breast cancer patients who underwent mastectomy. Total DNA was extracted from all samples and the entire mtDNA (16.6kb) was amplified using long range PCR amplification. The amplified PCR products were sequenced using mtDNA next-generation sequencing (NGS) on an Illumina Miseq platform. Sequencing involves the entire mtDNA (16.6kb) from all pairs of samples with high-coverage (~ 9,544 reads per base). MtDNA variants were called and annotated using mtDNA-Server, a web server. A total of 18 of 20 patients had at least one somatic mtDNA mutation in their tumour samples. Overall, 65 somatic mutations were identified, with 30 novel mutations. The majority (59%) of the somatic mutations were in the coding region, whereas only 11% of the mutations occurred in the D-loop. Notably, somatic mutations in protein-coding regions were non-synonymous (49%) in which 15.4% of them are potentially deleterious. A total of 753 germline mutations were identified and four of which were novel mutations. Compared to somatic alterations, less than 1% of germline missense mutations are harmful. The findings of this study may enhance the current knowledge of mtDNA alterations in breast cancer. To date, the catalogue of mutations identified in this study is the first evidence of mtDNA alterations in Malaysian female breast cancer patients.
first_indexed 2024-03-06T10:42:16Z
format Article
id upm.eprints-86771
institution Universiti Putra Malaysia
language English
last_indexed 2024-03-06T10:42:16Z
publishDate 2020
publisher Public Library of Science
record_format dspace
spelling upm.eprints-867712021-11-16T04:24:43Z http://psasir.upm.edu.my/id/eprint/86771/ Mitochondrial DNA mutations in Malaysian female breast cancer patients Omasanggar, Raevathi Yu, Choo Yee Ang, Geik Yong Emran, Nor Aina Kitan, Normayah Baghawi, Anita Ahmad, Atiki Falparado Abdullah, Maizaton Atmadini Teh, Lay Kek Maniam, Sandra Cancer development has been ascribed with diverse genetic variations which are identified in both mitochondrial and nuclear genomes. Mitochondrial DNA (mtDNA) alterations have been detected in several tumours which include lung, colorectal, renal, pancreatic and breast cancer. Several studies have explored the breast tumour-specific mtDNA alteration mainly in Western population. This study aims to identify mtDNA alterations of 20 breast cancer patients in Malaysia by next generation sequencing analysis. Twenty matched tumours with corresponding normal breast tissues were obtained from female breast cancer patients who underwent mastectomy. Total DNA was extracted from all samples and the entire mtDNA (16.6kb) was amplified using long range PCR amplification. The amplified PCR products were sequenced using mtDNA next-generation sequencing (NGS) on an Illumina Miseq platform. Sequencing involves the entire mtDNA (16.6kb) from all pairs of samples with high-coverage (~ 9,544 reads per base). MtDNA variants were called and annotated using mtDNA-Server, a web server. A total of 18 of 20 patients had at least one somatic mtDNA mutation in their tumour samples. Overall, 65 somatic mutations were identified, with 30 novel mutations. The majority (59%) of the somatic mutations were in the coding region, whereas only 11% of the mutations occurred in the D-loop. Notably, somatic mutations in protein-coding regions were non-synonymous (49%) in which 15.4% of them are potentially deleterious. A total of 753 germline mutations were identified and four of which were novel mutations. Compared to somatic alterations, less than 1% of germline missense mutations are harmful. The findings of this study may enhance the current knowledge of mtDNA alterations in breast cancer. To date, the catalogue of mutations identified in this study is the first evidence of mtDNA alterations in Malaysian female breast cancer patients. Public Library of Science 2020-05-22 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/86771/1/Mitochondrial%20DNA%20mutations%20in%20Malaysian%20female%20breast%20cancer%20patients.pdf Omasanggar, Raevathi and Yu, Choo Yee and Ang, Geik Yong and Emran, Nor Aina and Kitan, Normayah and Baghawi, Anita and Ahmad, Atiki Falparado and Abdullah, Maizaton Atmadini and Teh, Lay Kek and Maniam, Sandra (2020) Mitochondrial DNA mutations in Malaysian female breast cancer patients. PLoS One, 15 (5). pp. 1-18. ISSN 1932-6203 https://journals.plos.org/plosone/ 10.1371/journal.pone.0233461
spellingShingle Omasanggar, Raevathi
Yu, Choo Yee
Ang, Geik Yong
Emran, Nor Aina
Kitan, Normayah
Baghawi, Anita
Ahmad, Atiki Falparado
Abdullah, Maizaton Atmadini
Teh, Lay Kek
Maniam, Sandra
Mitochondrial DNA mutations in Malaysian female breast cancer patients
title Mitochondrial DNA mutations in Malaysian female breast cancer patients
title_full Mitochondrial DNA mutations in Malaysian female breast cancer patients
title_fullStr Mitochondrial DNA mutations in Malaysian female breast cancer patients
title_full_unstemmed Mitochondrial DNA mutations in Malaysian female breast cancer patients
title_short Mitochondrial DNA mutations in Malaysian female breast cancer patients
title_sort mitochondrial dna mutations in malaysian female breast cancer patients
url http://psasir.upm.edu.my/id/eprint/86771/1/Mitochondrial%20DNA%20mutations%20in%20Malaysian%20female%20breast%20cancer%20patients.pdf
work_keys_str_mv AT omasanggarraevathi mitochondrialdnamutationsinmalaysianfemalebreastcancerpatients
AT yuchooyee mitochondrialdnamutationsinmalaysianfemalebreastcancerpatients
AT anggeikyong mitochondrialdnamutationsinmalaysianfemalebreastcancerpatients
AT emrannoraina mitochondrialdnamutationsinmalaysianfemalebreastcancerpatients
AT kitannormayah mitochondrialdnamutationsinmalaysianfemalebreastcancerpatients
AT baghawianita mitochondrialdnamutationsinmalaysianfemalebreastcancerpatients
AT ahmadatikifalparado mitochondrialdnamutationsinmalaysianfemalebreastcancerpatients
AT abdullahmaizatonatmadini mitochondrialdnamutationsinmalaysianfemalebreastcancerpatients
AT tehlaykek mitochondrialdnamutationsinmalaysianfemalebreastcancerpatients
AT maniamsandra mitochondrialdnamutationsinmalaysianfemalebreastcancerpatients